Atherosclerosis
Volume 204, Issue 2 , Pages 476-482 , June 2009

Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals

  • Michelle A. Micallef

      Affiliations

    • Nutraceuticals Research Group, School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, NSW, Australia
    • ,
  • Manohar L. Garg

      Affiliations

    • Nutraceuticals Research Group, School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, NSW, Australia
    • Hunter Medical Research Institute, John Hunter Hospital, New Lambton, NSW, Australia
    • Corresponding Author InformationCorresponding author at: Nutraceuticals Research Group, School of Biomedical Sciences, The University of Newcastle, 305C Medical Sciences Building, Callaghan, NSW 2308, Australia. Tel.: +61 2 49215647; fax: +61 2 49212028.

Received 20 May 2008 ,Revised 22 June 2008 ,Accepted 11 September 2008.

References 

  1. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis. 2006;189:19–30
  2. Calder PC. Dietary modification of inflammation with lipids. Proc Nutr Soc. 2002;61:345–358
  3. Castro IA, Barroso LP, Sinnecker P. Functional foods for coronary heart disease risk reduction: a meta-analysis using a multivariate approach. Am J Clin Nutr. 2005;82:32–40
  4. Meydani SN, Endres S, Woods MM, et al. Effect of oral n-3 fatty acid supplementation on the immune response of young and older women. Adv Prostaglandin Thromboxane Leukot Res. 1991;21A:245–248
  5. De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA, Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb. 1994;14:1829–1836
  6. Bucher HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med. 2002;112:298–304
  7. Noakes M, Clifton P, Doornbos A, Trautwein E. Plant sterol ester-enriched milk and yoghurt effectivley reduce serum cholesterol in modestly hypercholesterolemic subjects. Eur J Nutr. 2005;44:214–222
  8. Valkema AJ. The influence of phytosterols on the absorption of cholesterol. Acta Physiol Pharmacol Neerl. 1955;4:291–292
  9. Ostlund RE. Phytosterols in human nutrition. Annu Rev Nutr. 2002;22:533–549
  10. Micallef MA, Garg ML. The lipid-lowering effects of phytosterols and (n-3) polyunsaturated fatty acids are synergistic and complementary in hyperlipidemic men and women. J Nutr. 2008;138:1086–1090
  11. Genest J, Frohlich J, Fodor G, McPherson R. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. CMAJ. 2003;169:921–929
  12. Grundy SM, Pasternak R, Greenland P, Smith SJ, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 1999;100:1481–1492
  13. Wilson PW, D’Agostino RB, Levy B, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–1847
  14. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79–83
  15. Pradelles P, Grassi J, Maclouf J. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem. 1985;57:1170–1173
  16. Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res. 1986;27:114–120
  17. De Caterina R, Cybulsky MA, Clinton SK, Gimbrone MA, Libby P. Omega-3 fatty acids and endothelial leukocyte adhesion molecules. Prostaglandins Leukot Essent Fatty Acids. 1995;52:191–195
  18. Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA, Calder PC. Dietary supplementation with gamma-linoleic acid or fish oil decreases T-lymphocyte proliferation in healthy older humans. J Nutr. 2001;131:1918–1927
  19. Halvorsen DA, Hansen JB, Grimsgaard S, Bonna KH, Kierulf P, Nordoy A. The effect of highly purified eicosapentaenoic and docosahexaenoic acids on monocyte phagocytosis in man. Lipids. 1997;32:935–942
  20. Kew S, Mesa MD, Tricon S, Buckley R, Minihane AM, Yaqoob P. Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on immune cell composition and function in healthy humans. Am J Clin Nutr. 2004;79:674–681
  21. Clifton PM, Mano M, Duchateau GS, van der Knaap HC, Trautwein EA. Dose-response effects of different plant sterol sources in fat spreads on serum lipids and C-reactive protein and on the kinetic behavior of serum plant sterols. Eur J Clin Nutr. 2007;1–10
  22. Houweling AH, Vanstone CA, Trautwein EA, Duchateau GS, Jones PJ. Baseline plasma plant sterol concentrations do not predict changes in serum lipids, C-reactive protein (CRP) and plasma plant sterols following intake of a plant sterol-enriched food. Eur J Clin Nutr. 2007;
  23. De Jong A, Plat J, Bast A, Godschalk RW, Basu S, Mensink RP. Effects of plant sterol and stanol ester consumption on lipid metabolism, antioxidant status and markers of oxidative stress, endothelial function and low-grade inflammation in patients on current statin treatment. Eur J Clin Nutr. 2008;62:263–273
  24. Devaraj S, Autret BC, Jialal I. Reduced-calorie orange juice beverage with plant sterols lowers C-reactive protein concentrations and improves the lipid profile in human volunteers. Am J Clin Nutr. 2006;84:756–761
  25. Jaye M. LXR agonists for the treatment of atherosclerosis. Curr Opin Investig Drugs. 2003;4:1053–1058
  26. Ridker PM, Rifai N, Pfeffer M. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation. 2000;101:2149–2153
  27. Esteve E, Ricart W, Fernandez-Real JM. Dyslipidemia and inlfammation: an evolutionary conserved mechanism. Clin Nutr. 2005;24:16–31
  28. Tsimikas S, Willerson JT, Ridker PM. C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol. 2006;47:C19–C31
  29. Albert CM, Campos H, Stampfer MJ, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002;346:1113–1118
  30. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747–2757
  31. Marchioli R, Barzi F, Bomba E, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation. 2002;105:1897–1903
  32. Mori TA. Omega-3 fatty acids and hypertension in humans. Clin Exp Pharmacol Physiol. 2006;33:842–846

PII: S0021-9150(08)00676-X

doi: 10.1016/j.atherosclerosis.2008.09.020

Atherosclerosis
Volume 204, Issue 2 , Pages 476-482 , June 2009

Article Tools

* Image Usage & Resolution